These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1415805)

  • 1. Platelet-activating factor antagonists limit glycine changes and behavioral deficits after brain trauma.
    Faden AI; Tzendzalian PA
    Am J Physiol; 1992 Oct; 263(4 Pt 2):R909-14. PubMed ID: 1415805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet-activating factor antagonists decrease the inflammatory nociceptive response in rats.
    Teather LA; Magnusson JE; Wurtman RJ
    Psychopharmacology (Berl); 2002 Oct; 163(3-4):430-3. PubMed ID: 12373444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of platelet-activating factor (PAF) antagonists and nitric oxide in cardiac actions of PAF. Electrophysiological and morphological study.
    Kecskeméti V; Balogh I
    J Physiol Pharmacol; 2000 Dec; 51(4 Pt 1):723-35. PubMed ID: 11192945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Platelet-activating factor (PAF) antagonists].
    Terasawa M
    Tanpakushitsu Kakusan Koso; 1991 Feb; 36(3):379-87. PubMed ID: 1850862
    [No Abstract]   [Full Text] [Related]  

  • 5. Role of platelet-activating factor in hepatic responses after bile duct ligation in rats.
    Zhou W; Chao W; Levine BA; Olson MS
    Am J Physiol; 1992 Nov; 263(5 Pt 1):G587-92. PubMed ID: 1443133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet-activating factor antagonist BN 50730 attenuates hypoxic-ischemic brain injury in neonatal rats.
    Liu XH; Eun BL; Barks JD
    Pediatr Res; 2001 Jun; 49(6):804-11. PubMed ID: 11385142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dexamethasone-induced gastric mucosal damage in the rat: possible role of platelet-activating factor.
    Filep JG; Hermán F; Földes-Filep E; Schneider F; Braquet P
    Br J Pharmacol; 1992 Apr; 105(4):912-8. PubMed ID: 1324056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of PAF antagonists on cerulein-induced pancreatitis.
    Jancar S; Abdo EE; Sampietre SN; Kwasniewski FH; Coelho AM; Bonizzia A; Machado MC
    J Lipid Mediat Cell Signal; 1995 Jan; 11(1):41-9. PubMed ID: 7537159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet activating factor and systemic anaphylaxis in Nippostrongylus brasiliensis-sensitized rats: differential effects of PAF antagonists.
    Mathison R; Davison JS; Befus AD
    Br J Pharmacol; 1992 Jun; 106(2):263-6. PubMed ID: 1393261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of platelet-activating factor in pancreatitis-associated acute lung injury in the rat.
    Zhou W; McCollum MO; Levine BA; Olson MS
    Am J Pathol; 1992 Apr; 140(4):971-9. PubMed ID: 1562055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Phospholipid thrombocyte activating factor, its analogs and antagonists: prospects of their use in medicine].
    Kulikov VI; Muzia GI
    Vestn Akad Med Nauk SSSR; 1991; (10):13-7. PubMed ID: 1801455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet-activating factor antagonists reduce excitotoxic damage in cultured neurons from embryonic chick telencephalon and protect the rat hippocampus and neocortex from ischemic injury in vivo.
    Prehn JH; Krieglstein J
    J Neurosci Res; 1993 Feb; 34(2):179-88. PubMed ID: 8095559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enterolobin induces rat paw oedema independently of PAF-acether.
    Castro-Faria-Neto HC; Cordeiro RS; Martins MA; Correia-Da-Silva AC; Bozza PT; Sousa MV; Morhy L
    Mem Inst Oswaldo Cruz; 1991; 86 Suppl 2():129-31. PubMed ID: 1841984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PAF-induced amplification of mediator release in septic shock: prevention or downregulation by PAF antagonists.
    Koltai M; Hosford D; Braquet P
    J Lipid Mediat; 1993; 6(1-3):183-98. PubMed ID: 8357981
    [No Abstract]   [Full Text] [Related]  

  • 15. Platelet activating factor antagonists do not alter normal cerebral blood flow or cerebral oxygen consumption.
    Kochanek PM; Melick JA; Schoettle RJ; Magargee MJ; Evans RW; Nemoto EM
    Adv Exp Med Biol; 1990; 277():345-51. PubMed ID: 2096640
    [No Abstract]   [Full Text] [Related]  

  • 16. Platelet-activating factor induces cell death in cultured astrocytes and oligodendrocytes: involvement of caspase-3.
    Hostettler ME; Knapp PE; Carlson SL
    Glia; 2002 May; 38(3):228-39. PubMed ID: 11968060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet-activating factor reduces spinal cord blood flow and causes behavioral deficits after intrathecal administration in rats through a specific receptor mechanism.
    Faden AI; Halt P
    J Pharmacol Exp Ther; 1992 Jun; 261(3):1064-70. PubMed ID: 1602373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of platelet activating factor antagonists on the protamine sulphate stimulated release of histamine from peritoneal mast cells of rats in vitro.
    Lohde C; Bahr T; Labes D; Grupe R
    Arzneimittelforschung; 1992 Jan; 42(1):27-31. PubMed ID: 1375025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for platelet-activating factor as a late-phase mediator of chronic pancreatitis in the rat.
    Zhou WG; Chao W; Levine BA; Olson MS
    Am J Pathol; 1990 Dec; 137(6):1501-8. PubMed ID: 1701964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The platelet-activating factor antagonist BN 52021 attenuates hypoxic-ischemic brain injury in the immature rat.
    Liu XH; Eun BL; Silverstein FS; Barks JD
    Pediatr Res; 1996 Dec; 40(6):797-803. PubMed ID: 8947953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.